76.34
                                            Schlusskurs vom Vortag:
              $75.97
            Offen:
              $75.88
            24-Stunden-Volumen:
                103.37K
            Relative Volume:
              2.62
            Marktkapitalisierung:
                $N/A
            Einnahmen:
              -
            Nettoeinkommen (Verlust:
              -
            KGV:
              -
            EPS:
                -
            Netto-Cashflow:
                -
            1W Leistung:
              +1.62%
            1M Leistung:
              +0.97%
            6M Leistung:
                +14.30%
            1J Leistung:
              +10.76%
            Ishares U S Pharmaceuticals Etf Stock (IHE) Company Profile
Firmenname
                  
                      Ishares U S Pharmaceuticals Etf
                    
                Sektor
                  Branche
                  Telefon
                  
                      -
                    
                Adresse
                  
                      -
                    
                Vergleichen Sie IHE mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV | 
|---|---|---|---|---|---|---|
| 
                         
                          
                                IHE
                            
                             
                        Ishares U S Pharmaceuticals Etf 
                           | 
                    76.34 | 0 | 0 | 0 | 0 | 0.00 | 
| 
                         
                          
                                VTI
                            
                             
                        Vanguard Total Stock Market Etf 
                           | 
                    335.80 | 417.53B | 0 | 0 | 0 | 0.00 | 
| 
                         
                          
                                SPY
                            
                             
                        Spdr S P 500 Etf Trust 
                           | 
                    683.34 | 372.57B | 0 | 0 | 0 | 0.00 | 
| 
                         
                          
                                IVV
                            
                             
                        Ishares Core S P 500 Etf 
                           | 
                    686.69 | 253.41B | 0 | 0 | 0 | 0.00 | 
| 
                         
                          
                                VB
                            
                             
                        Vanguard Small Cap Etf 
                           | 
                    254.42 | 160.59B | 0 | 0 | 0 | 0.00 | 
| 
                         
                          
                                QQQ
                            
                             
                        Invesco Qqq Trust Series 1 
                           | 
                    632.08 | 124.43B | 0 | 0 | 0 | 0.00 | 
Ishares U S Pharmaceuticals Etf Aktie (IHE) Neueste Nachrichten
ETFs in Focus on Eli Lilly's Solid Q2 Earnings, Weak Obesity Data - MSN
Eli Lilly Extends Lead In $150B Obesity Drug Race As Novo, Pfizer Clash — Here's How ETFs Stand To Gain - Benzinga
Is iShares U.S. Pharmaceutical ETF stock a top dividend aristocrat candidateEarnings Risk Report & Daily Growth Stock Tips - newser.com
Is iShares U.S. Pharmaceutical ETF stock attractive post correctionJuly 2025 Final Week & Community Consensus Stock Picks - newser.com
Should You Invest in the Invesco Pharmaceuticals ETF (PJP)? - sharewise.com
How dovish Fed policy supports iShares U.S. Pharmaceutical ETF stockQuarterly Portfolio Summary & Expert Curated Trade Setup Alerts - newser.com
How iShares U.S. Pharmaceutical ETF stock trades under stagflationTrade Entry Summary & Weekly Setup with ROI Potential - newser.com
Can iShares U.S. Pharmaceutical ETF stock test all time highs2025 Earnings Impact & High Conviction Trade Alerts - newser.com
Is iShares U.S. Pharmaceutical ETF stock positioned for secular growthMarket Movement Recap & High Accuracy Buy Signal Tips - newser.com
ETFs to Watch Post JNJ's Q3 Earnings Surprise & Bullish Outlook - TradingView
Truist Financial Corp Has $593,000 Holdings in iShares U.S. Pharmaceuticals ETF $IHE - Defense World
Short bets on S&P 500 Healthcare sector rises marginally to 1.91% in September; MRNA remains most shorted stock - MSN
3,967 Shares in iShares U.S. Pharmaceuticals ETF $IHE Acquired by Wealth Enhancement Advisory Services LLC - Defense World
Here's How This Pharmaceutical Giant Is Protecting Itself From President Trump's Tariffs. Should It Matter to Investors? - The Motley Fool
Can iShares U.S. Pharmaceutical ETF stock double in coming yearsQuarterly Portfolio Report & Long-Term Growth Portfolio Plans - newser.com
4 Reasons to Buy Pharma ETFs Now for a Healthy Portfolio - sharewise.com
Pharma ETFs In A Tariff Storm: How Investors Can Hedge Risk - inkl
How iShares U.S. Pharmaceutical ETF stock trades in high volatilityJuly 2025 Earnings & Entry and Exit Point Strategies - newser.com
Trump's 100% Drug Tariff Will Hit Americans, Economist Says Buyers 'Eat The Cost,' Not Foreign Firms - Sahm
U.S. Capital Wealth Advisors LLC Has $437,000 Stock Holdings in iShares U.S. Pharmaceuticals ETF $IHE - Defense World
Trump’s Pharma Tariffs Boost US Drug Stocks as Europe’s and Asia’s Drop - NTD News
Trump Slams 100% Tariff on Imported Drugs: Pharma ETFs Take a Hit - Yahoo Finance
Should You Invest in the VanEck Pharmaceutical ETF (PPH)? - sharewise.com
10 Best Pharma Stocks to Buy According to Billionaires - Insider Monkey
iShares U.S. Pharmaceuticals ETF declares quarterly distribution of $0.3124 - MSN
Is Invesco Pharmaceuticals ETF (PJP) a Strong ETF Right Now? - sharewise.com
Mark Cuban Exposes How Wholesalers Force Pharmacies Into Near-Exclusive Deals, Detailing PBMs' 'Stranglehold' On Drug Pricing - Benzinga
Raymond James Financial Inc. Sells 6,443 Shares of iShares U.S. Pharmaceuticals ETF $IHE - Defense World
How Is Bristol-Myers’ Stock Performance Compared to Other Pharma Stocks? - Yahoo Finance
BlackRock calls out state officials for ‘politicization’ of public pensions - ESG Dive
How Is Regeneron’s Stock Performance Compared to Other Pharma Stocks? - Inkl
Should You Invest in the iShares U.S. Pharmaceuticals ETF (IHE)? - sharewise.com
HighTower Advisors LLC Has $944,000 Stock Holdings in iShares U.S. Pharmaceuticals ETF $IHE - Defense World
XLV Vs. IHE: Will Pharmaceuticals Outperform Healthcare? (NYSEARCA:XLV) - Seeking Alpha
PNC Financial Services Group Inc. Acquires 216 Shares of iShares U.S. Pharmaceuticals ETF $IHE - Defense World
Should You Invest in the iShares U.S. Financials ETF (IYF)? - Yahoo Finance
LPL Financial LLC Has $2.88 Million Stock Holdings in First Trust Nasdaq Pharmaceuticals ETF $FTXH - Defense World
U.S.-India Trade Talks Collapse: Implications for Global Supply Chains and Emerging Market Equity Exposure - AInvest
Short bets on S&P 500 Healthcare sector ease in July; Moderna remains most heavily shorted stock - MSN
Should You Invest in the iShares U.S. Industrials ETF (IYJ)? - Yahoo Finance
IAT: Rate Cuts Back In Play, Regional Banks Poised To Benefit - Seeking Alpha
Should You Invest in the iShares U.S. Healthcare ETF (IYH)? - Yahoo Finance
Cetera Investment Advisers Purchases 1,613 Shares of iShares U.S. Insurance ETF (NYSEARCA:IAK) - Defense World
iShares U.S. Energy ETF (NYSEARCA:IYE) Holdings Cut by Blair William & Co. IL - Defense World
4. SPDR S&P Pharmaceuticals ETF (ARCA:XPH) - Investing News Network
AbbVie Announces $195 Million Investment to Expand Active Pharmaceutical Ingredient Manufacturing in the U.S. - Investing News Network
Should You Invest in the iShares U.S. Technology ETF (IYW)? - Yahoo Finance
Pharma ETFs: Your Key to Diversification in the Pharmaceutical Sector - Investing News Network
Cetera Investment Advisers Sells 5,940 Shares of iShares U.S. Transportation ETF (BATS:IYT) - Defense World
Cetera Investment Advisers Acquires 299 Shares of KraneShares CSI China Internet ETF (NYSE:KWEB) - Defense World
LPL Financial LLC Has $8.46 Million Stock Holdings in iShares U.S. Pharmaceuticals ETF (NYSEARCA:IHE) - Defense World
Finanzdaten der Ishares U S Pharmaceuticals Etf-Aktie (IHE)
        Es liegen keine Finanzdaten für Ishares U S Pharmaceuticals Etf (IHE) vor. Überprüfen Sie andere Aktien für weitere Informationen.
    
Umsatz
Nettogewinn
Free Cashflow
ENV
        In Yahoo öffnen
        |
        In Google öffnen
            |
            In Finviz öffnen
        |
        In MarketWatch öffnen
            |
            Öffnen Sie in EDGAR    
        |
        Offen in Reuters
    
    
                Kapitalisierung:
                 
                  | 
                Volumen (24h):